FDA Dispute Resolution Process Should Be Less Structured, Merck Exec Says
Executive Summary
Industry wants FDA's dispute resolution process to allow for less structured interaction during the appeals process, Merck Manufacturing Quality Assurance Director David Haggard said
You may also be interested in...
FDA’s Overhaul Of GMP Oversight Will Include Numerous Targeted Guidances
FDA is developing an ad hoc guidance process for manufacturing issues through which it will issue short recommendations based on specific circumstances
FDA’s Overhaul Of GMP Oversight Will Include Numerous Targeted Guidances
FDA is developing an ad hoc guidance process for manufacturing issues through which it will issue short recommendations based on specific circumstances
GMP Dispute Resolution Pilot To Cover Scientific And Technical Issues Only
An FDA dispute resolution pilot will cover scientific and technical Good Manufacturing Practice issues but not procedural or administrative matters